lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma

Cisplatin-based chemotherapy and radiotherapy are the main first-line treatment strategies for nasopharyngeal carcinoma (NPC) patients. Unfortunately, resistance is a major obstacle in the clinical management of NPC patients. We prove that the expression level of high-mobility group box 1 (HMGB1) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xuewei, Liu, Li, Wang, Yang, Cong, Jianan, Lin, Zhang, Wang, Yongsen, Liu, Qi, Wang, Leiming, Yang, Ben, Li, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173225/
https://www.ncbi.nlm.nih.gov/pubmed/34094941
http://dx.doi.org/10.3389/fonc.2021.651693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173225/
https://www.ncbi.nlm.nih.gov/pubmed/34094941
http://dx.doi.org/10.3389/fonc.2021.651693

Ejemplares similares